Literature DB >> 9379273

Lengths of hamstrings and psoas muscles during crouch gait: effects of femoral anteversion.

L M Schutte1, S W Hayden, J R Gage.   

Abstract

Recent studies of muscle lengths measured by means of gait analysis data and musculoskeletal models have suggested that in many cases of crouch gait in patients with cerebral palsy, the hamstrings are of normal length and the psoas muscles are short. In these studies, however muscle lengths were calculated by applying kinematic data from a child's joint to a normal adult model. Children with cerebral palsy and other disorders generally do not have normal bone architecture but instead have muscle attachment points and muscle paths altered by osseous deformities. In this study, we explored the consequences of using normal adult musculoskeletal models to calculate hamstring and psoas lengths for children with cerebral palsy. Specifically, for a group of subjects with cerebral palsy who walk with a crouch gait, we investigated the changes in muscle lengths that arise when a patient-specific representation of clinically measured femoral anteversion was added to a model of normal musculoskeletal geometry. The calculation of psoas muscle length was found to be very sensitive to femoral anteversion whereas the calculation of hamstrings length was found to be relatively insensitive to this osseous deformity.

Entities:  

Mesh:

Year:  1997        PMID: 9379273     DOI: 10.1002/jor.1100150419

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  11 in total

1.  [The value of instrumented gait analysis in infantile cerebral palsy].

Authors:  L Döderlein; S Wolf
Journal:  Orthopade       Date:  2004-10       Impact factor: 1.087

2.  Pre-operative hamstring length and velocity do not explain the reduced effectiveness of repeat hamstring lengthening in children with cerebral palsy and crouch gait.

Authors:  Melisa Osborne; Nicole M Mueske; Susan A Rethlefsen; Robert M Kay; Tishya A L Wren
Journal:  Gait Posture       Date:  2018-11-28       Impact factor: 2.840

3.  Variation of hamstrings lengths and velocities with walking speed.

Authors:  Kiran J Agarwal-Harding; Michael H Schwartz; Scott L Delp
Journal:  J Biomech       Date:  2010-04-08       Impact factor: 2.712

4.  The role for hip surveillance in children with cerebral palsy.

Authors:  Benjamin Shore; David Spence; Hk Graham
Journal:  Curr Rev Musculoskelet Med       Date:  2012-06

5.  Validity of gait parameters for hip flexor contracture in patients with cerebral palsy.

Authors:  Sun Jong Choi; Chin Youb Chung; Kyoung Min Lee; Dae Gyu Kwon; Sang Hyeong Lee; Moon Soek Park
Journal:  J Neuroeng Rehabil       Date:  2011-01-23       Impact factor: 4.262

6.  The effect of distal femoral extension osteotomy on muscle lengths after surgery.

Authors:  R L Lenhart; C R Smith; M H Schwartz; T F Novacheck; D G Thelen
Journal:  J Child Orthop       Date:  2017-12-01       Impact factor: 1.548

7.  Is Femoral Version Associated with Changes in Hip Muscle Strength in Females with Symptomatic Femoroacetabular Impingement?

Authors:  Adriano David Marostica; André Luiz Almeida Pizzolatti; Guilherme Pradi Adam; Daniel Codonho; Richard Prazeres Canella; Gerson Gandhi Ganev
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2019-08-20

8.  Botulinum Toxin Type A Injections Impact Hamstring Muscles and Gait Parameters in Children with Flexed Knee Gait.

Authors:  Seung Ki Kim; Dong Wook Rha; Eun Sook Park
Journal:  Toxins (Basel)       Date:  2020-02-27       Impact factor: 4.546

9.  Hamstring and psoas length of crouch gait in cerebral palsy: a comparison with induced crouch gait in age- and sex-matched controls.

Authors:  Tae-Yon Rhie; Ki Hyuk Sung; Moon Seok Park; Kyoung Min Lee; Chin Youb Chung
Journal:  J Neuroeng Rehabil       Date:  2013-01-30       Impact factor: 4.262

10.  Determinants of Hip and Femoral Deformities in Children With Spastic Cerebral Palsy.

Authors:  Yoona Cho; Eun Sook Park; Han Kyul Park; Jae Eun Park; Dong-Wook Rha
Journal:  Ann Rehabil Med       Date:  2018-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.